Market Indices
Latest News
 |
from Craig-Hallum issued a price target of $2.00 for June 3, 2026 CRDF -7.28% |
| ||
| ||
| ||
|
Price Targets
from Craig-Hallum issued a price target of $2.00 for CRDF on 2026-06-03 16:01:01.The adjusted price target was set to $2.00.At the time of the announcement, CRDF was...
June 3, 2026 CRDF -7.28%
from Northland Securities issued a price target of $125.00 for AXTI on 2026-06-03 13:25:24.The adjusted price target was set to $125.00.At the time of the announcement, AXTI...
June 3, 2026 AXTI -3.56%
from UBS issued a price target of $8.00 for RRGB on 2026-06-03 13:05:00.The adjusted price target was set to $8.00.At the time of the announcement, RRGB was...
June 3, 2026 RRGB -6.59%
from Truist Financial issued a price target of $616.00 for PRAX on 2026-06-02 12:05:35.The adjusted price target was set to $616.00.At the time of the announcement, PRAX...
June 2, 2026 PRAX 5.64%
Ben Haynor from Lake Street issued a price target of $235.00 for NUTX on 2026-06-02 12:02:00.The adjusted price target was set to $235.00.At the time of the announcement,
June 2, 2026 NUTX 1.14%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SYRS Syros Pharmaceuticals, In | 0.00
19,900.00% | ||||||||||||||||||
| XOSWW Xos Equity Warrants | 0.01
560.00% | ||||||||||||||||||
| ATPC Agape ATP Corporation | 4.38
47.49% | ||||||||||||||||||
| DRTSW Alpha Tau Medical Ltd. Wa | 2.30
19.79% | ||||||||||||||||||
| VBNK VersaBank | 20.72
14.29% | ||||||||||||||||||
| DRTS Alpha Tau Medical Ltd. | 10.14
13.55% | ||||||||||||||||||
| APM Aptorum Group Limited | 1.08
10.66% | ||||||||||||||||||
| TLYS Tilly's, Inc. | 4.92
10.07% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -1.85%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -11.15%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 1.93%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -2.24%